Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Open-Label, Single-Arm Study of YONDELIS (Trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment

Trial Profile

A Multicenter, Open-Label, Single-Arm Study of YONDELIS (Trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Oct 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Trabectedin (Primary)
  • Indications Ewing's sarcoma; Osteosarcoma; Soft tissue sarcoma
  • Focus Adverse reactions; Expanded access
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 12 Sep 2017 Results of a retrospective analysis assessing the efficacy and safety of trabectedin in an elderly patient subgroup with advanced leiomyosarcoma (LMS) or liposarcoma, presented at the 42nd European Society for Medical Oncology Congress.
    • 12 Sep 2017 Results (n=1803) of retrospective analysis assessing efficacy and safety of patients treated long-term with trabectedin on the expanded access program, were presented at the 42nd European Society for Medical Oncology Congress.
    • 17 Nov 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top